Article

Drug delivery firm hires medical expert

Evry, France—Novagali Pharma, a drug delivery specialty company using cationic emulsions to develop age-related macular degeneration treatments, has hired Florence Barouki-Binlich, MD, as its vice president for development and medical affairs.

Evry, France-Novagali Pharma, a drug delivery specialty company using cationic emulsions to develop age-related macular degeneration treatments, has hired Florence Barouki-Binlich, MD, as its vice president for development and medical affairs.

Dr. Barouki-Binlich will be responsible for all stages of pharmaceutical development, including regulatory affairs, preclinical and clinical research, finding investigators, and analyzing results. Her appointment comes as the company prepares to launch preclinical and clinical trials in ophthalmology (cyclosporine formulations) and oncology.

She most recently spent 4 years at Bayer Pharma (France), where she headed the company's Therapeutic Group.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.